Beth Rogozinski

Beth Rogozinski has extensive work experience in the healthcare and technology sectors. Beth is currently the Chief Executive Officer of Oncoustics, a company that specializes in using AI to differentiate healthy and diseased tissues using raw ultrasound signals. Beth also serves as an Advisor for Modality.AI, UnitedHealth Group, A4i, and FireflyVR. Additionally, Beth has held positions as an Independent Board Director for Mentia, Inc., Koa Health, and Neolth Inc. Beth has also served as a Senior Advisor for the National Mental Health Innovation Center and as a UCSF Startup 101 Advisor/Mentor for the UCSF Entrepreneurship Center. Overall, Beth's experience showcases their expertise in AI-driven healthcare solutions and their commitment to transforming the healthcare industry.

Beth Rogozinski completed their MBA in Marketing and Management at the San Francisco State University, Lam Family College of Business from 2003 to 2005. Additionally, they also pursued an MBA in Marketing, Management, and Branding at San Francisco State University - CSU during the same period.